IQVIA

IQVIA

Yahoo Finance • 13 days ago

Locking in Gains: Portfolio Discipline Triggers IQVIA Holding (IQV) Trim After Q2 Beat

Broyhill Asset Management, a Charlotte-based firm, issued its third-quarter 2026 investor letter. The letter can be downloaded here. The Broyhill Equity Composite decreased by 0.3% in Q3, underperforming the MSCI All Country World Index, w... Full story

Yahoo Finance • 18 days ago

1 Large-Cap Stock to Research Further and 2 We Avoid

1 Large-Cap Stock to Research Further and 2 We Avoid Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further... Full story

Yahoo Finance • 18 days ago

Global Clinical Trials Market Size, Share, Trends, and Forecast, 2026-2033 | Market to Reach USD 158.4 Billion at 7.7% CAGR as Decentralized Trials and R&D Outsourcing Accelerate

Company Logo New Report puts the global market at $89bn in 2025, with chronic and rare disease, precision medicine and outsourcing to contract researchers driving growth — and IQVIA, ICON, Parexel, Pfizer and Roche among the 20 companies... Full story

Yahoo Finance • 21 days ago

Drug Development Inputs & Services Stocks Q2 In Review: Charles River Laboratories (NYSE:CRL) Vs Peers

Drug Development Inputs & Services Stocks Q2 In Review: Charles River Laboratories (NYSE:CRL) Vs Peers Wrapping up Q2 earnings, we look at the numbers and key takeaways for the drug development inputs & services stocks, including Charles... Full story

Yahoo Finance • 28 days ago

These healthcare stocks have the highest EPS revision grade ahead of Q3 results

[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images As Q3 2026 earnings season approaches, healthcare stocks are drawing investor attention as markets assess earnings e... Full story

Yahoo Finance • 29 days ago

UBS flags 56 stocks where growth and profitability may be underpriced

[Hands holding up columns of bar graph] We Are UBS Global Research has constructed a 56-stock basket of U.S. companies with higher forward growth, stronger cash-flow profitability and improving earnings momentum, arguing that valuations f... Full story

Yahoo Finance • 29 days ago

IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes

RESEARCH TRIANGLE PARK, N.C., October 07, 2026--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, tod... Full story

Yahoo Finance • last month

1 S&P 500 Stock with Competitive Advantages and 2 We Turn Down

1 S&P 500 Stock with Competitive Advantages and 2 We Turn Down The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn't mean every stock is worth owning. Some companies face significant challenges, whether... Full story

Yahoo Finance • last month

Pharmacovigilance Software Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)

Company Logo The global pharmacovigilance software market is projected to grow from USD 4.5 billion in 2026 to USD 12.7 billion by 2036, at a 10.9% CAGR. Growth is driven by stricter drug safety regulations, expanding clinical trials, ris... Full story

Yahoo Finance • 2 months ago

IQVIA Stock Rises 60% in 6 Months: Here's What You Should Know

IQVIA IQV stock has surged 60.1% in the past six months. The company's shares outpaced the industry's 4.1% return and the Zacks S&P 500 Composite's 14% rally. 6-Month Share Price PerformanceZacks Investment Research Image Source: Zacks I... Full story

Yahoo Finance • 2 months ago

A Strong Rebound Case of IQVIA Holdings (IQV)

Broyhill Asset Management, a Charlotte-based firm, issued its second-quarter 2026 investor letter, which is available for download here. The Broyhill Equity Composite gained 8.8% in Q2, trailing the MSCI All Country World Index's 15.1% and... Full story

Yahoo Finance • 2 months ago

Why Is NeuroPace (NPCE) Down 0.4% Since Last Earnings Report?

It has been about a month since the last earnings report for NeuroPace, Inc. (NPCE). Shares have lost about 0.4% in that time frame, outperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings releas... Full story

Yahoo Finance • 2 months ago

IQVIA prices $2B of senior notes due 2034

IQVIA Holdings (IQV [https://seekingalpha.com/symbol/IQV]) announced on Wednesday that its wholly owned subsidiary, IQVIA, priced an offering of $2B in aggregate principal amount of senior notes due 2034. The proceeds from the notes offer... Full story

Yahoo Finance • 2 months ago

1 Profitable Stock with Solid Fundamentals and 2 That Underwhelm

1 Profitable Stock with Solid Fundamentals and 2 That Underwhelm Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn't mean it will... Full story

Yahoo Finance • 2 months ago

IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster

RESEARCH TRIANGLE PARK, N.C., September 03, 2026--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, today announced IQVIA Predictive Clinical Develo... Full story

Yahoo Finance • 2 months ago

VEEV Raises FY27 Outlook as Vault CRM and AI Momentum Accelerate Fast

Veeva Systems Inc. VEEV raised its fiscal 2027 outlook after second-quarter revenues increased 17.6% year over year to $928 million. Vault CRM adoption and broader commercial execution added another positive signal. The question is how qu... Full story

Yahoo Finance • 2 months ago

Here's Why You Should Retain IQVIA Stock in Your Portfolio Now

Shares of IQVIA IQV have had an excellent run over the past month. The stock has gained 21.7% compared with the industry and the Zacks S&P 500 Composite's growth of 9.7% and 3.5%, respectively. The company's third-quarter 2026 earnings ar... Full story

Yahoo Finance • 3 months ago

IQVIA Ranked No. 1 Pharmaceutical Technology Provider by Everest Group

RESEARCH TRIANGLE PARK, N.C., August 17, 2026--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, toda... Full story

Yahoo Finance • 3 months ago

Unpacking Q2 Earnings: Repligen (NASDAQ:RGEN) In The Context Of Other Drug Development Inputs & Services Stocks

Unpacking Q2 Earnings: Repligen (NASDAQ:RGEN) In The Context Of Other Drug Development Inputs & Services Stocks Quarterly earnings results are a good time to check in on a company's progress, especially compared to its peers in the same s... Full story

Yahoo Finance • 3 months ago

Stock futures edge lower as traders focus on Strait of Hormuz reopening

[The New York Stock Exchange on the Wall street sign] Dmitry Vinogradov Stock index futures were lower on Tuesday as traders continued to focus on developments related to the reopening of the Strait of Hormuz. Dow futures (INDU [https://... Full story